Clinical Trial: Proteome-Wide Association and LLM-Based Prioritization of Type 2 Diabetes Protein Targets

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07832656) titled 'Proteome-Wide Association and LLM-Based Prioritization of Type 2 Diabetes Protein Targets' on Sept. 15.

Brief Summary: Type 2 diabetes is a common condition in which the body has difficulty controlling blood sugar. This study will use existing genetic, protein, and health data from prior research studies to identify blood proteins that may play a role in type 2 diabetes. The study will not recruit participants, provide treatment, or collect new samples. Researchers will use computer-based analyses to identify and prioritize protein targets for future laboratory and clinical research. The goal is to support the development of better...